CAACB News & Events
News
| CAACB and the Biomanufacturing Research Program to be presented at the Annual Bio-Manufacturing & Process Innovation Leaders Summit in Boston (June 11, 2013) Dr. Stacy L. Springs, Executive Director of the CAACB and Biomanufacturing Research Program (BioMAN) will present Leveraging Collaborative Innovation: The BioMAN Research Program and Consortium on Adventitious Agent Contamination in Biomanufacturing. |
| CAACB Initiative to be presented at the PDA European Virus & TSE Safety Forum in Berlin. (June 4-6, 2013) Dr. Michael Wiebe, Lead Investigator of the CAACB will present The MIT / Industry Initiative on Preventing Adventitious Agent Contamination in Biomanufacturing. Read Abstract |
| The CBI’s Consortium on Adventitious Agent Contamination in Biopharmaceutical Manufacturing featured in Nature editorial. (April 28, 2011) A recent Nature editorial discusses the problem of viral contamination in biopharmaceutical manufacturing. The editorial highlights the work being done at MIT, through the CAACB, and the potential positive impact on the biopharmaceutical industry. Read More. |
| MIT CBI launches new biopharmaceutical manufacturing industry initiative to tackle adventitious agent contamination. (January 1, 2011) The MIT Center for Biomedical Innovation has launched a new industrial initiative, the Consortium on Adventitious Agent Contamination in Biomanufacturing (CAACB), beginning to address an industry-wide problem. With vital industry participation, the CAACB will collect, analyze and share industry risks and prevention strategies regarding adventitious agent contamination. |
Event Partner
The Biomanufacturing Research Program (BioMAN) and the CAACB are
Event Partners for IBC’s BioProcess International Conference & Exhibition
September 16 – 19, 2013
Hynes Convention Center, Boston, MA
IBC’s conference program will provide you with practical strategies and solutions in process development (upstream and downstream), analytics, quality control and formulation/delivery to help you manage the increasingly diverse portfolio of biologicals progressing through the industry’s collective pipeline. By attending, you will also learn about the changing landscape of biomanufacturing, and gain new ideas to help keep nimble and efficient in the emerging world of single-use technologies, flexible bioproduction, multi-product facilities and global manufacturing.
As an Event Partner, IBC is offering our community a 20% discount off of the standard rate.
Please visit www.IBCLifeSciences.com/BPI to register and reference BPI13CBI for your 20% courtesy discount.
Events
| June 24-25, 2013 | The MIT CBI’s Consortium on Adventitious Agent Contamination in Biomanufacturing to host a workshop on Virus Risk Assessment Approaches at the MIT Faculty Club (June 24) and the Boston Marriott Cambridge (June 25). |
| April 17, 2013 | Dr. James C. Leung, Lead Investigator of the CAACB, presented An Academic and Industry Collaborative Initiative on Preventing Adventitious Agent Contaminations in Biomanufacturing at the Center for Biomedical Innovation’s Seminar Series at MIT. |
| March 15, 2013 | Dr. James C. Leung, Lead Investigator of the CAACB, presented An Academic and Industry Collaborative Initiative on Preventing Adventitious Agent Contaminations in Biomanufacturing at the IS Biotech 3rd Annual Meeting in Rosslyn, VA. |
| February 26, 2013 | Dr. Michael Wiebe, Lead Investigator of the CAACB, presented The MIT / Industry Initiative on Preventing Adventitious Agent Contamination in Biomanufacturing during the Viral Safety for Biologics session at the IBC Biopharmaceutical Development and Production week in Huntington Beach, CA. |
| December 13, 2012 | The MIT CBI’s Consortium on Adventitious Agent Contamination in Biomanufacturing hosted a workshop on Virus Contamination at the MIT Faculty Club on December 13th. The workshop consisted of open discussions centered around the viral contamination data collected from our Consortium members. The event brought together more than 40 people from 15 different companies and organizations. |
| June 21-22, 2012 | The MIT CBI’s Consortium on Adventitious Agent Contamination in Biomanufacturing hosted a workshop on Media Treatment in Biomanufacturing at the MIT Faculty Club on June 21st and 22nd. The workshop consisted of 1.5 days of talks, open discussion and networking centered around High Temperature Short Time treatment of cell culture media to inactivate adventitious agents as well as several alternative methods, such as UV-C treatment. The event brought together more than 50 people from 19 different companies and organizations. |
| June 28-30, 2011 | Dr. Houman Dehghani, of Amgen, presented “Maximize the Knowledge of Past Virus Contamination Events to Benefit the Future – An MIT-led and Industry-Sponsored Project” about the CAACB initiative at the PDA’s Virus and TSE Safety Forum in Barcelona. |
| December 1, 2010 | Dr. Michael Wiebe presented “Industry Consortium on Adventitious Agent Contamination in Biomanufacturing” at the PDA/FDA workshop on Adventitious Viruses in Biologics: Detection and Mitigation Strategies |
| November 17, 2010 | CAACB Initiative presented at 2010 BioMAN Summit “Science to Manage Risk in Biomanufacturing” |
| November 17, 2010 | Consortium on Adventitious Agent Contamination in Biomanufacturing Kick-off Meeting |